IBX 6.25% 7.5¢ imagion biosystems limited

26 May 2021First-in-human study update: First patient...

  1. 92 Posts.
    lightbulb Created with Sketch. 58
    26 May 2021
    First-in-human study update: First patient enrolled
    MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare
    through the earlier detection of cancer, is pleased to announce that the first patient has been enrolled in the
    MagSense® HER2 breast cancer Phase I first-in-human study.

    Note that this was a market sensitive relase so why not now with "multiple patients"?
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
-0.005(6.25%)
Mkt cap ! $2.611M
Open High Low Value Volume
7.6¢ 7.6¢ 7.5¢ $3.934K 52.28K

Buyers (Bids)

No. Vol. Price($)
2 20000 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 28750 1
View Market Depth
Last trade - 11.51am 11/07/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.